Live Breaking News & Updates on அதிர்வெண் வரம்புகள்

Stay updated with breaking news from அதிர்வெண் வரம்புகள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Advanced computer model could lead to improvements in 'bionic eye' technology


Advanced computer model could lead to improvements in bionic eye technology
There are millions of people who face the loss of their eyesight from degenerative eye diseases. The genetic disorder retinitis pigmentosa alone affects 1 in 4,000 people worldwide.
Today, there is technology available to offer partial eyesight to people with that syndrome. The Argus II, the world s first retinal prosthesis, reproduces some functions of a part of the eye essential to vision, to allow users to perceive movement and shapes.
While the field of retinal prostheses is still in its infancy, for hundreds of users around the globe, the bionic eye enriches the way they interact with the world on a daily basis. For instance, seeing outlines of objects enables them to move around unfamiliar environments with increased safety. ....

Gianluca Lazzi , Fredh Cole , Emily Henderson , Viterbi School Of Engineering , Institute For Technology , Keck School Of Medicine , Provost Professor , Electrical Engineering , Keck School , Neural Systems , Rehabilitation Engineering , Scientific Reports , Genetic Disorder , Retinitis Pigmentosa , எமிலி ஹென்டர்சன் , விட்டர்பி பள்ளி ஆஃப் பொறியியல் , நிறுவனம் க்கு தொழில்நுட்பம் , கேக்க் பள்ளி ஆஃப் மருந்து , புரோஸ்ட் ப்ரொஃபெஸர் , மின் பொறியியல் , கேக்க் பள்ளி , நரம்பியல் அமைப்புகள் , புனர்வாழ்வு பொறியியல் , அறிவியல் அறிக்கைகள் , ஜெநெடிக் கோளாறு ,

Completion of Chubu Electric Power Grid Hida Converter Station Equipped with Hitachi's Frequency Converters


Completion of Chubu Electric Power Grid Hida Converter Station Equipped with Hitachi s Frequency Converters
Contributing to a stable supply of electricity by enabling efficient interconnection between Tokyo and Chubu regions with HVDC Technology
TOKYO, Apr 1, 2021 - (JCN Newswire) - Hitachi, Ltd. (TSE: 6501) announced that the operations of the Hida-Shinano frequency conversion facility have commenced, enabling the Shin-Shinano Substation of TEPCO Power Grid, Inc. (TEPCO) to be connected to the Hida Converter Station of Chubu Electric Power Grid Co., Inc. (Chubu Electric Power), to which Hitachi delivered a line commutate converter high-voltage direct current (HVDC) system.
The Hida-Shinano frequency conversion facility is a direct current transmission system with an interconnection capacity of 900MW, connecting the 60 Hz-based Chubu Electric Power area and the 50 Hz-based TEPCO area via an approximately 89 km long aerial cable. In the wake of the Great East Japan Eart ....

Japan General , Chubu Electric Power Grid Co Inc , Hitachi Ltd , International Council On Large Electric Systems , A Survey Of The Reliability , Power Grid Inc , Shin Shinano Substation , Hida Converter Station , Chubu Electric Power , Great East Japan Earthquake , High Voltage Direct Current , Higashishimizu Substation , International Council , Large Electric Systems , Social Innovation Business , Smart Life , ஜப்பான் ஜநரல் , சுபு மின்சார பவர் கட்டம் இணை இன்க் , ஹிட்டாச்சி லிமிடெட் , சர்வதேச சபை ஆன் பெரியது மின்சார அமைப்புகள் , பவர் கட்டம் இன்க் , தாடை ஷினானோ துணை மின்நிலையம் , ஹிடா மாற்றி நிலையம் , சுபு மின்சார பவர் , நன்று கிழக்கு ஜப்பான் பூகம்பம் , உயர் மின்னழுத்தம் நேரடி தற்போதைய ,

Study evaluates effectiveness of hormone therapies in managing postmenopausal nocturia


Study evaluates effectiveness of hormone therapies in managing postmenopausal nocturia
As women age, they are more likely to wake up in the middle of the night to pass urine. The loss of estrogen during the menopause transition accelerates this problem, which is known as nocturia.
A new study evaluated the effectiveness of different hormone therapies in managing the frequency of nocturia. Study results are published online today in
Menopause, the journal of The North American Menopause Society (NAMS).
The loss of estrogen during menopause has been shown to create bladder dysfunction, sleep disorders, hot flashes, and alterations in renal water and salt handling, all of which result in higher diuresis overnight. ....

United States , Stephanie Faubion , Emily Henderson , American Menopause Society , North American Menopause Society , Medical Director , North American Menopause , ஒன்றுபட்டது மாநிலங்களில் , மாற்றாந்தாய் போஉபிொன் , எமிலி ஹென்டர்சன் , அமெரிக்கன் மாதவிடாய் சமூகம் , வடக்கு அமெரிக்கன் மாதவிடாய் சமூகம் , மருத்துவ இயக்குனர் , வடக்கு அமெரிக்கன் மாதவிடாய் ,

High-speed Chemical Resistant Diaphragm Pumps Introduced


Mar 17 2021 Read 158 Times
Wiggens is pleased to introduce the C-series of chemical resistant diaphragm pumps which are suitable for use in in the chemical, pharmaceutical, petrochemical and other industries, such as suction filtration, vacuum distillation, rotational evaporation, vacuum concentration, centrifugal concentration and solid phase extraction, to name a few.
C-series pumps are driven by diaphragm, with no additional belt-driven transmission, which eliminates the need of lubricant, regular oil and maintenance. All wetted parts of C series pump are made of PTFE which is ideal for extremely aggressive/corrosive gases and vapours. The sealing system provides reduced leakage rates for improved ultimate vacuum (1mbar). ....

Clinical trial begins to evaluate SENSE device's ability to monitor intracranial hemorrhage


Clinical trial begins to evaluate SENSE device’s ability to monitor intracranial hemorrhage
Sense Diagnostics, a medical technology company focused on improving outcomes for stroke and brain injury patients, announced the initiation of a multicenter pivotal trial to evaluate the safety and efficacy of a non-invasive brain scanner to monitor intracranial hemorrhage (ICH) in an acute hospital setting. The SENSE device is a headset equipped with antennae that transmit a low-power tailored radio frequency (RF) pulse across the brain and uses an algorithm to detect signal changes that may indicate an expansion in ICH.
The trial, titled A Prospective, Two-Stage, Non-randomized, Multi-center Within Patient Comparison Study to Evaluate the SENSE Device s Ability to Monitor Intracranial Hemorrhage, follows positive in vitro and in vivo proof of concept studies and a successful first in human feasibility study. The trial will enroll up to 400 patients with a diagnostic head CT s ....

United States , Opeolu Adeoye , Emily Henderson , Drug Administration , Multi Center Within Patient Comparison Study , Monitor Intracranial Hemorrhage , Chief Medical Officer , Sense Diagnostics , Medical Director , Clinical Trial , Ischemic Stroke , Radio Frequency , Traumatic Brain Injury , ஒன்றுபட்டது மாநிலங்களில் , எமிலி ஹென்டர்சன் , பல மையம் உள்ளே நோயாளி ஒப்பீடு படிப்பு , தலைமை மருத்துவ அதிகாரி , உணர்வு பரிசோதனை , மருத்துவ இயக்குனர் , மருத்துவ சோதனை , வானொலி அதிர்வெண் , அதிர்ச்சிகரமான மூளை காயம் ,